Website stats for Alkermes - alkermes.com
ResponsibilityWe champion an approach that views patients holistically and with compassion. Working together with stakeholders across the healthcare community, our team is focused on cutting-edge science, developing innovative medicines and patient-focused advocacy to make a real-world impact in the lives of people living with difficult-to-treat conditions.Visit our Responsibility page
alkermes.com was registered 2 decades 9 years ago. It has a alexa rank of #1,580,513 in the world. It is a domain having .com extension. It is estimated worth of $ 720.00 and have a daily income of around $ 3.00. As no active threats were reported recently, alkermes.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 555 |
| Daily Pageviews: | 1,110 |
Estimated Valuation
| Income Per Day: | $ 3.00 |
| Estimated Worth: | $ 720.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 1,580,513 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
72.32.33.202
Hosted Country:
US
Location Latitude:
29.4997Location Longitude:
-98.3992Search Engine Results For alkermes.com
Alkermes - Crunchbase Company Profile & Funding
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
Alkermes Email Format | alkermes.com Emails - RocketReach
Alkermes uses 5 email formats: 1. first '.' [email protected] (97.9%). Enter a name to find & verify an email >>>
Alkermes | Pharmaceutical Manufacturing
Company Profile: Alkermes ... As part of Alkermes plc, Alkermes Contract Pharma Services provides solid oral dosage product development,scale-up and ...
Alkermes, Inc. Company Profile | Waltham, MA | Competitors ...
Alkermes, Inc. is located in Waltham, MA, United States and is part of the Pharmaceutical Manufacturing Industry. Alkermes, Inc. has 570 total employees across ...
Jobs with Alkermes - BioSpace
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases.
Alkermes plc (ALKS) Stock Price, News, Quote & History - Yahoo ...
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in ...
Alkermes Contract Pharma Services - Pharmaceutical Technology
As part of Alkermes plc, Alkermes Contract Pharma Services provides solid oral dosage product development, scale-up and manufacturing services and sterile ...
Alkermes Company Profile: Stock Performance & Earnings | PitchBook
Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical ...
Booth Preview
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company ...
Alkermes Inc - Company Profile and News - Bloomberg Markets
Alkermes, Inc. develops pharmaceutical products. The Company produces medications for debilitating diseases such as multiple sclerosis, schizophrenia, ...
Alkermes – A global biopharmaceutical company
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology.
Alkermes | National Association of Addiction Treatment Providers
Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases.
ALKS.O - Alkermes Plc Profile | Reuters
23 days ago. Alkermes Announces FDA Approval Of Lybalvi For The Treatment Of Schizophrenia And Bipolar I Disorder · 2 months ago. Alkermes Posts Q1 Non- ...
Alkermes - Corporate Social Responsibility (CSR), Sustainability ...
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields...
Alkermes Contract Pharma Services - Outsourcing Pharma
45 years of providing outsourcing solutions to our partners Who we are, what we do Alkermes Contract Pharma Services provides solid oral dosage product ...
Alkermes - definition of Alkermes by The Free Dictionary
Biopharmaceutical company Alkermes plc (Nasdaq:ALKS) revealed on Monday the planned resignation of Jim Robinson with effect from 19 April 2019 for ...
Alkermes Brand | Comparably
Alkermes is ranked second among its competitors. Biogen and Alnylam Pharmaceuticals come in first and third, with Reata Pharmaceuticals coming in at #4.
Catherine Potter - Google Scholar
Alkermes Pharma Ireland Ltd. Verified email at alkermes.com. Process Analytical TechnologyRaman SpectroscopyAmorphous Solid DispersionsContinuous ...
Alkermes Company Profile - Office Locations, Competitors, Revenue ...
Alkermes has 2245 employees across 4 locations and $1.04 B in annual revenue in FY 2020. See insights on Alkermes including office locations, competitors, ...
ALKS Stock Price & Charts | Alkermes - YCharts
In depth view into ALKS (Alkermes) stock including the latest price, news, dividend history, earnings information and financials.
Alkermes (NasdaqGS:ALKS) - Share price, News & Analysis ...
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in ...
Alkermes plc. SEC Registration - SEC Report
Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical ...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | Not Applicable | H2 Headings: | 1 |
| H3 Headings: | 6 | H4 Headings: | 1 |
| H5 Headings: | 6 | H6 Headings: | Not Applicable |
| Total IFRAMEs: | 1 | Total Images: | 16 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| in the | 6 | 1.071 % | No |
| 2021 Alkermes | 4 | 0.714 % | No |
| people living | 3 | 0.536 % | No |
| living with | 3 | 0.536 % | No |
| Read more | 3 | 0.536 % | No |
| Privacy Policy | 3 | 0.536 % | No |
| difficulttotreat diseases | 3 | 0.536 % | No |
| to make | 3 | 0.536 % | No |
| make a | 3 | 0.536 % | No |
| of our | 3 | 0.536 % | No |
| Press Releases | 2 | 0.357 % | No |
| to our | 2 | 0.357 % | No |
| our employees | 2 | 0.357 % | No |
| Corporate Responsibility | 2 | 0.357 % | No |
| medicines and | 2 | 0.357 % | No |
| the lives | 2 | 0.357 % | No |
| Contact Us | 2 | 0.357 % | No |
| neuroscience and | 2 | 0.357 % | No |
| lives of | 2 | 0.357 % | No |
| of people | 2 | 0.357 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| lives of people living | 2 | 0.357 % | No |
| of people living with | 2 | 0.357 % | No |
| the lives of people | 2 | 0.357 % | No |
| synaptic dysfunction in neuroscience | 1 | 0.179 % | No |
| dysfunction in neuroscience and | 1 | 0.179 % | No |
| in neuroscience and immune | 1 | 0.179 % | No |
| including synaptic dysfunction in | 1 | 0.179 % | No |
| platforms including synaptic dysfunction | 1 | 0.179 % | No |
| our scientific platforms including | 1 | 0.179 % | No |
| scientific platforms including synaptic | 1 | 0.179 % | No |
| neuroscience and immune modulation | 1 | 0.179 % | No |
| and immune modulation in | 1 | 0.179 % | No |
| View our pipeline Preclinical | 1 | 0.179 % | No |
| our pipeline Preclinical Phase | 1 | 0.179 % | No |
| pipeline Preclinical Phase 1 | 1 | 0.179 % | No |
| oncology View our pipeline | 1 | 0.179 % | No |
| in oncology View our | 1 | 0.179 % | No |
| immune modulation in oncology | 1 | 0.179 % | No |
| modulation in oncology View | 1 | 0.179 % | No |
| from our scientific platforms | 1 | 0.179 % | No |
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Cache-Control: no-cache
Pragma: no-cache
Content-Type: text/html; charset=utf-8
Content-Encoding: gzip
Expires: -1
Vary: Accept-Encoding
Server: Microsoft-IIS/10.0
X-AspNetMvc-Version: 5.2
X-AspNet-Version: 4.0.30319
X-Powered-By: ASP.NET
Content-Security-Policy: frame-ancestors https://admin.alkermes.com https://www.alkermes.com
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
Date: Mon, 07 Jun 2021 20:37:12 GMT
Content-Length: 8135
Domain Information
| Domain Registrar: |
Network Solutions, LLC
|
|---|---|
| Registration Date: | 1995-10-03 2 decades 9 years 1 month ago |
| Last Modified: | 2020-10-02 4 years 1 month 2 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns59.worldnic.com | |
162.159.26.165 | United States |
| ns60.worldnic.com | |
162.159.27.8 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| alkermes.com | A | 3592 |
IP: 72.32.33.202 |
| alkermes.com | NS | 7200 |
Target: ns60.worldnic.com |
| alkermes.com | NS | 7200 |
Target: ns59.worldnic.com |
| alkermes.com | SOA | 7200 |
MNAME: NS59.WORLDNIC.com RNAME: namehost.WORLDNIC.com Serial: 121060710 Refresh: 10800 Retry: 3600 Expire: 604800 |
| alkermes.com | MX | 7200 |
Priority: 10 Target: mxa-00049901.gslb.pphosted.com |
| alkermes.com | MX | 7200 |
Priority: 10 Target: mxb-00049901.gslb.pphosted.com |
| alkermes.com | TXT | 7200 |
TXT: docusign=ceb9cdce-be3e-4b8a-8841-ac68176 405f8 |
| alkermes.com | TXT | 7200 |
TXT: cisco-ci-domain-verification=1bbcda3ede4 09f09d8637bc63f3b4d10e2565eeb8c10bad0b99 0db1029041e55 |
| alkermes.com | TXT | 7200 |
TXT: docusign=c5b9c7d2-6a95-430a-84e2-8ed1787 ff829 |
| alkermes.com | TXT | 7200 |
TXT: tP5HlxzA3cZ7PhwgbDp9JODgMzgfcobInlMx7of1 YLyAyB8hGj1pAdc+jWTASRvgwC9TiCs3bQOmclEv AlrE6w== |
| alkermes.com | TXT | 3600 |
TXT: MS=ms79269034 |
| alkermes.com | TXT | 7200 |
TXT: v=spf1 ip4:155.212.24.4 include:spf-00049901.pphosted.com include:mailgun.org include:spf.agiloft.com ~all |
| alkermes.com | TXT | 7200 |
TXT: webexdomainverification.4C675B8BB1ADB136 E053AB06FC0A3F65=b9cc6e58-4374-4932-bfe9 -45379b041e7e |
Full WHOIS Lookup
Registry Domain ID:
5361793_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.networksolutions.com
Registrar URL:
http://networksolutions.com
Updated Date:
2020-10-02T05:06:58Z
Creation Date:
1995-10-03T04:00:00Z
Registry Expiry Date:
2030-10-02T04:00:00Z
Registrar: Network Solutions,
LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.8003337680
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
NS59.WORLDNIC.COM
Name Server: NS60.WORLDNIC.COM
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2021-06-07T20:36:50Z
Similarly Ranked Websites
Welcome to Enlightenment! – Religion: the Tragedy of Mankind....
Uncompromising exposure of the counterfeit origins of Christianity and of the evil it has brought to the world.
1,580,527 
$ 720.00
Animal taboo - All animal taboo sex on one page. Zoo porn, animal...
1,580,533 $ 720.00
I want MORE porn - Free sex videos and HD XXX porn tube movies
1,580,534 $ 720.00
HOME | 株式会社 東京測器研究所
東京測器研究所の応力測定機器は社会および経済のインフラストラクチュアを構築する車両、航空機、船舶、道路、建築物などの安全設計や災害予知、新工法といった土木技術などの最先端で活躍しています。応力測定機器の専業メーカとして独自の技術力を培い、さまざまな分野の技術の進展に貢献しています。ひずみゲージは、測定対象の材質、形状や測定内容、条件などに合わせてお選び...
1,580,547 $ 720.00
Bug Bounty Forum
Bug Bounty Forum is a 150+ large community of security researchers sharing information with each other.
1,580,556 $ 720.00